Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting120%
completed240%
unknown240%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Magnetoencephalography (MEG) Pilot Study

NCT07446192
completednot_applicable

Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis

NCT04553224
unknownnot_applicable

Imaging Biomarker in Cancer Drug Induced ILD

NCT03294746
unknownnot_applicable

Understand FoG in PD: Behavioral Physiology and Clinical Application

NCT02987140
completed

Long Term Effects of Erythrocyte Lysis

NCT00842621

Clinical Trials (5)

Showing 5 of 5 trials
NCT07446192Not Applicable

Magnetoencephalography (MEG) Pilot Study

Recruiting
NCT04553224Not Applicable

Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis

Completed
NCT03294746Not Applicable

Imaging Biomarker in Cancer Drug Induced ILD

Unknown
NCT02987140Not Applicable

Understand FoG in PD: Behavioral Physiology and Clinical Application

Unknown
NCT00842621

Long Term Effects of Erythrocyte Lysis

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5